ShowPDF Paper.aspx
ShowPDF Paper.aspx
RESEARCH ARTICLE
ABSTRACT:
The present study to describe the Quantification of Itopride Hydrochloride from tablet dosage form by visible
spectroscopy by applying principle of colorimetric study. It involves the measurement of the amount of
ultraviolet (190-380 nm) or visible (380-800nm) radiation absorbed by a substance in solution. The final
optimised method carried out on double beam UV-visible spectrophotometer (Shimadzu, model 1800) having
two matched quartz cells with 1 cm light path by using Bromothymol blue of concentration 0.5% w/v solution.
Itopride Hydrochloride detection wavelength was set at 479.40nm The linearity was found to be in the range of
10-50μg/ml. This method for the quantitative determination of the drug by validation in accordance with the
International Conference on Harmonization. The proposed method is economic, simple, sensitive, reproducible,
and accurate and no interference is observed due to common excipients of tablet. The proposed method was
successfully applied to determination of Itopride hydrochloride in pharmaceutical formulations.
121
Research J. Pharm. and Tech. 11(1): January 2018
b) The interference from irrelevant absorption may be hydrochloride is chemically Hydrochloride salt of N-{[4-
avoided by converting the analyte to a derivative which (2- dimethylamino ethoxy) phenyl] methyl}-3, 4-
absorbs in the visible region, where irrelevant absorption
dimethoxy-benzamide is an anti-emetic drug and used in
is negligible the management of gastrointestinal symptoms like
nausea, vomiting, non ulcer dyspepsia, emesis and
c) Indirect spectrophotometric procedures are also used chronic gastritis5, 6, 7.
to improve the selectivity of an ultraviolet-absorbing
substance in a sample that contains other ultraviolet-
absorbing components.
diluting 1 ml of stock solution to 10 ml with distilled different time points on different days and %RSD was
water with the same prepare different dilution in the calculated.
range of 10-50 μg/ml
Repeatability:
Preparation of calibration curve: Repeatability was carried out by using a minimum of 6
To 5 ml of each dilution taken in separating funnel, 5 ml determinations at one of the test concentration.
of bromothymol blue solution was added and shaken
vigorously. Then 2.5 ml of chloroform was added LOD AND LOQ:
reaction mixture was shaken vigorously and allowed to The LOD and LOQ were estimated from the set of6
stand so as to separate aqueous and chloroform layer. calibration curves used to determine method linearity.
The chloroform layer was separate out and transferred to LOD= 3.3*σ/S and LOQ= 10*σ/S
5 ml volumetric flask. Reaction mixture extracted further Where,
with 1.5 and 1 ml of fresh chloroform and added in σ = the standard deviation of y-intercepts of regression
previously extracted chloroform layer containing drug. lines
Scanned final solution wavelength was found 479.40nm. S = the slope of the calibration curve
Measure the absorbance of various dilutions at this
wavelength. Calibration curve was plotted between Ruggedness
concentration of drug and measured absorbance. The evaluation of Ruggedness should be considered
during the development phase and depends on the type
Analysis of tablet formulation: of procedure under study. It should show the reliability
Twenty tablets were accurately weighed and average of an analysis with respect to external factors in method
weight of tablet was determined. Tablets were to fine parameters such as instrument, analyst variation.
powder equivalent to 10 mg Itopride hydrochloride.
Dissolved weighed quantity of tablet powder in distilled RESULT AND DISCUSSION:
water. Sonicated for 15 min and filtered through
whatman filter paper. Filter paper was washed with
distilled water and made the volume to 100ml. From this
solution 3 ml was taken in 10 ml volumetric flask and
volume was made with distilled water to give
concentration of 30 µg/ml and followed same procedure
as per calibration curve. The absorbance of prepared
dilution was measured at 479.40 nm wavelength.
Concentration of drug in formulation was calculated
from calibration curve. Procedure repeated three times.
Figure 3: UV Spectrum of Itopride Hydrochloride
VALIDATION OF DEVELOPED METHOD12
Linearity: Wavelength final solution was found to be 479.40nm.
The linearity was determined by analyzing 6 Table 1 Linearity
independent levels of calibration curve in the range of Sr. No. Conc Absorbance
10-50μg/ml. Absorbance of each solution was recorded. 1 0 0
Absorbance vs. concentration was plotted and 2 10 0.0303
correlation co-efficient and regression line equation for 3 20 0.0608
4 30 0.0875
Itraconazole were determined. 5 40 0.1155
6 50 0.1389
Accuracy:
Accuracy was determined by performing recovery
studies within the analytical concentration range of the
proposed method at three different set at level of 80%,
100% and 120%. The amount of Itopride hydrochloride
and % Recoveries was calculated at each level.
Precision:
Inter-day precision was determined by analyzing Itopride
hydrochloride (10-50μg/ml) at three different time points
of the same day and Intra-day was determined by
analyzing Itopride hydrochloride (10-50 μg/ml) at three Figure 4 Calibration curve for Itopride Hydrochloride
123
Research J. Pharm. and Tech. 11(1): January 2018
124
Research J. Pharm. and Tech. 11(1): January 2018
Interday (n=3)
10µg/ml 0.50
20 µg/ml 1.95
30 µg/ml 0.52
Intraday(n=3)
10 µg/ml 0.80
20 µg/ml 1.01
30 µg/ml 0.98
8 Repeatability(n=6)%RSD 1.30
9 LOD 9.173
LOQ 27.79
10 Ruggedness (n=6)%RSD
Analyst I 0.77
Analyst II 1.51
CONCLUSION:
The proposed method was economic, simple, sensitive,
reproducible, and accurate and no interference was
observed due to common excipients of tablet. Statistical
analysis of the result has been carried out revealing high
accuracy and good precision. The proposed method was
successfully applied to the determination of Itopride
hydrochloride in pharmaceutical formulations. Thus the
proposed method can be used for the routine analysis of
Itopride hydrochloride in bulk as well as in its
pharmaceutical preparations.
REFERENCES:
1. Hobart H. Willard, Lynne L. Merritt, Jr, John A. Dean, Frank A.
Settle, Jr, Instrumental Method of Analysis, CBS Publication and
Distributor, Delhi, 7(2), 118-158.
2. A.H. Beckett and J.B. Stenlake, Practical Pharmaceutical
Chemistry, CBS Publisher and Distributor, Delhi, 4(2), 275-277.
3. A.H. Beckett and J.B. Stenlake, Practical Pharmaceutical
Chemistry, CBS Publisher and Distributor, Delhi, 4(2), 275-277.
4. A.H. Beckett and J.B. Stenlake, Practical Pharmaceutical
Chemistry, 4th Edition Part Two, CBS Publisher and Distributor,
Delhi, 4(2), 30.
5. http://www.druginfosys.com/drug.aspx?drugcode=1599andtype=
1. https://en.wikipedia.org/wiki/Itopride.
6. Kd. Tripathi, Essential of Medical Pharmacology, 6th Edition,
Jaypee Brohers, New Delhi, 627.
7. Hussainy, Areefulla S, Smitha G, Swamy PV, Raju SA.
Spectrophotometric Determination of Itopride Hydrochloride. Int.
J Chem. Sci 2006; 4(3): 713-716.
8. Singh SS, Jain M, Sharma K, Shah B, Vyas M, Thakpar P, Et Al.
Quantitation of Itopride In Human Serum By High Performance
Liquid Chromatography With Fluorescence Detection and Its
Application To A Bioequivalence Study. J Charatogr B Analyst
Technol Biomed Life Sci 2005; 818(2): 213-220.
9. Kaul N, Agrawal H, Maske, PR, Ramchandra J, Mahadik, KR,
Kadam, SS. Chromatographic Determination of Itopride
Hydrochloride In The Presence of Its Degradation Products. J
Separ Sci 2005; 28(13): 1566-1576.
10. Suganthi A, Karthikeyan R, Ravi TK. HPTLC Methods for
Estimation of Itopride Hydrochloride From Its Tablet
Formulations. Indian Drugs 2006; 43(10): 827-830.
11. Prof. Manohar A. Potdar, Pharmaceutical Quality Assurance, 3rd
Edition, October 2013, Nirali Prakashan, 8.28.
125